| Literature DB >> 32373755 |
Jian-Rong Yang1,2, Teng-Teng Ren1, Rongfeng Lan3, Xiao-Yan Qin1.
Abstract
Tea polyphenols (TP) are the major ingredients in tea beverages that display health-benefits including anti-oxidation, anti-inflammation, anti-aging, attenuating blood pressure and deflating. In this study, we investigated the neuroprotective effects of TP to attenuate staurosporine (STS)-induced cytotoxicity. Rat hippocampal neurons were isolated, cultured and incubated with STS to induce neurite collapse and apoptosis, however, the medication of TP eliminated these adverse effects and maintained the morphology of neurons. STS decreased the expression of pro-BDNF, downregulated the TrkB/Akt/Bcl-2 signaling axis and promoted the activation of Erk1/2 and caspase-3. In contrast, TP rescued the expression of pro-BDNF and antagonistically restored the biochemistry of aforementioned signaling effectors. Consistently, the activity of TP can be attenuated by the inhibition of TrkB or Akt by small chemicals K252a and LY294002. Therefore, BDNF-TrkB and Akt signaling axis is essential for TP-mediated neuroprotective effects. In summary, TP showed beneficial effects to protect neurons from exogenous insults such as STS-induced neural cytotoxicity and cell death.Entities:
Keywords: EC, (-)-epicatechin; ECG, (-)-epigallocatechin; EGC, (-)-epicatechin-3-gallate; EGCG, (-)-epigallocatechin-3-gallate; Erk1/2; K252a; LDH, Lactate dehydrogenase; LY, LY294002; LY294002; MAP2; MAP2, microtubule associated protein 2; PD98059; STS, staurosporine; Staurosporine; TP, tea polyphenols; TUNEL, terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling
Year: 2020 PMID: 32373755 PMCID: PMC7193097 DOI: 10.1016/j.ibror.2020.04.002
Source DB: PubMed Journal: IBRO Rep ISSN: 2451-8301
Fig. 1Tea polyphenols (TP) effectively attenuate STS-induced cytotoxicity and morphological collapse in hippocampal neurons. (A) STS inhibited cell viability in a dose-dependent manner. 0.4 μM of STS caused a decline of 40 % in cell viability. The scatter dot plot presented both mean ± s.e.m and individual values. ** p < 0.01 and *** p < 0.001 was examined in relative to the control group (STS = 0.0 μM). (B) TP rescued the cell viability in concentrations of 0.5–10 μM. # p < 0.05, ## p < 0.01, and ### p < 0.001 was calculated in relative to the set of STS = 0.4 μM. (C) LDH cytotoxicity assay confirmed the rescue of neurons from STS-induced toxicity by TP. (D-E) TUNEL assay verified the inhibition of STS-induced (0.4 μM) apoptosis by TP (10 μM), whereas the activity of TP was antagonized through the inhibition of TrkB activity mediated by K252a (0.2 μM). Scale bar = 50 μm. (***) or (###) p < 0.001 was calculated in relative to the control, STS, or STS + TP group, respectively; n.s, no significance. (F-H) TP (10 μM) rescued the neurons from STS-induced morphological collapse. Cells were immunofluorescence stained with β-III tubulin for visualizing the neurite (F), cell morphology (G), and DAPI for nuclei (H), Scale bar = 50 μM. STS treatment heavily destroyed the neurite and caused morphological collapse in neurons, responding to apoptotic nuclei indicated by DAPI staining. TP attenuated STS-induced toxicity and maintained the cell morphology.
Fig. 2TP protect hippocampal neurons against STS-induced cytotoxicity and morphological collapse depending on Akt signaling axis. (A) The optimal concentrations of K252a, LY294002 and PD98059 on hippocampal neurons. (B) Immunofluroscense staining showed the TP mediated maintenance of neural morphology against STS-induced cytotoxicity. Inhibition of the activity of TrkB or Akt by small chemical inhibitor K252a (0.2 μM) or LY294002 (10 μM), respectively, significantly antagonized the cytoprotective effects of TP. Scale bar = 100 μm.
Fig. 3TP ameliorate BDNF-TrkB and Akt/Erk1/2 signaling axis to attenuate STS-induced cytotoxicity. (A) STS decreased the expression of pro-BDNF and downregulated the TrkB-mediated signaling axis. However, TP medication rescued the pro-BDNF expression and reactivated the TrkB-mediated signaling axis. (*) p < 0.05, (**) p < 0.01 relative to the control group; (##) p < 0.01, or (n.s) no significant relative to the STS group; n = 3. (B) STS inhibited the activity of Akt indicating by its decreased phosphorylation, and oppositely activated Erk1/2. TP rescued the activation of Akt and attenuated STS-induced Erk1/2 activation. (C) TP restored the cell viability against STS-induced toxicity and could be blocked by the inhibition of TrkB or Akt. (***) p < 0.001 is corresponding to the control group; (###) p < 0.001 or (n.s) no significant is corresponding to the STS or STS + TP group. (D) TP antagonistically restored the biochemistry of apoptosis-associated regulators Bcl-2 and cleaved-caspase 3 (Csp3) to block STS-induced apoptosis. (*) p < 0.05 relative to the control group; (#) p < 0.05 relative to the STS group, n = 3. In this figure, TP = 10.0 μM; STS = 0.4 μM; K252a = 0.2 μM; LY294002 (LY) = 10.0 μM; PD98095 (PD) =20.0 μM.
Fig. 4A schematic model presents the effect of tea polyphenols (TP) in attenuating STS-induced cytotoxicity in hippocampal neurons. STS treatment induced cytotoxicity and morphological collapse in neurons, whereas TP medication rescued the neurons from STS-induced toxicity by restoring the expression of BDNF and associated TrkB-Akt and Bcl-2/caspase-3 signaling pathway to inhibit apoptosis.